The NCCN Guidelines Insights report (2023) provides updated recommendations for systemic therapy in metastatic breast cancer, emphasizing the integration of tumor biology and clinical factors. This update reflects the evolving understanding of breast cancer heterogeneity and its implications for treatment. By incorporating emerging evidence, the guidelines offer a framework for clinicians to tailor therapy to individual patient profiles, optimizing outcomes in stage IV breast cancer.